Frazier Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Frazier Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,566,912	Closed	-$56.9M	–	17
2021 Q4	$56.9M	Hold	3,566,912	–	–	4.38%	6
2021 Q3	$71.1M	Hold	3,566,912	–	–	5.69%	3
2021 Q2	$61.7M	Hold	3,566,912	–	–	5.69%	4
2021 Q1	$70.7M	Hold	3,566,912	–	–	5.67%	4
2020 Q4	$62.3M	Hold	3,566,912	–	–	4.8%	5
2020 Q3	$68.7M	Hold	3,566,912	–	–	6.17%	4
2020 Q2	$69.4M	Hold	3,566,912	–	–	6.1%	5
2020 Q1	$49.9M	Hold	3,566,912	–	–	5.66%	5
2019 Q4	$87.5M	Hold	3,566,912	–	–	14.67%	2
2019 Q3	$35.9M	Buy	+3,566,912	New	+$43.8M	11.22%	2

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management's MIRM Position: Q1 2022 in Review

Frazier Management sold out of Mirum Pharmaceuticals (MIRM) in Q1 2022, closing a stake of 3,566,912 shares — an estimated $56.9M sold.

Frazier Management first reported a position in MIRM in Q3 2019 and held it in 10 quarters. The position peaked at $87.5M in Q4 2019. 99 funds tracked by Wall St. Rank hold MIRM as of Q1 2022.

Frazier Management reported no remaining Mirum Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Frazier Management sold 3,566,912 Mirum Pharmaceuticals shares in Q1 2022, an estimated $56.9M.
Frazier Management first reported a position in Mirum Pharmaceuticals in Q3 2019 and held it in 10 quarters.
Frazier Management's Mirum Pharmaceuticals position peaked at $87.5M in Q4 2019.
99 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.